Deadline: Claim your Certificate of Attendance and CME/CE credits by Friday, November 13, 2026. The Evaluation Site closes after this date.
This document provides updated coding information for services related to assisted reproductive technology procedures. This document replaces the 2016 American Society for Reproductive Medicine
To evaluate the impact of elevated progesterone (P4) level on embryology outcomes in patients undergoing in vitro fertilization (IVF).
To establish gestational day-specific reference values for serum hCG in early pregnancy following embryo transfer and identify maternal and treatment-related factors contributing to its
To compare ongoing pregnancy rates between subcutaneous progesterone and vaginal progesterone supplemented with intramuscular progesterone every third day in programmed frozen embryo transfer
To investigate how endometrial thickness and pattern jointly relate to live birth in fresh and frozen-thawed embryo transfer cycles.
Uterus transplantation (UTx) has evolved from an experimental procedure to an increasingly established infertility treatment for women with absolute uterine-factor infertility. Despite procedural
“I need to do at least one more cycle… and there's no clear finish line.” This excerpt from a patient interview completed as part of the recent work by Voigt et al. (1) titled “Perceived
To evaluate the clinical outcome potential of embryos classified by preimplantation genetic testing for aneuploidy (PGT-A) as nonmosaic whole chromosome aneuploid (WCA) or segmental aneuploid (SA)
Polyendocrine metabolic ovarian syndrome (PMOS) is one of the most common endocrine disorders affecting reproductive-aged women and is increasingly recognized as a lifelong condition rather than
To determine whether supplemental estradiol treatment during the follicular phase of intrauterine insemination (IUI) cycles using letrozole and/or clomiphene for ovarian stimulation. improves
Displaying 911 to 920 of 1762 records
